3.20.1 html 128 351 1 false 45 0 false 6 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.interceptpharma.com/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00150 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 00400 - Statement - Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficitEquity Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity Statements 6 false false R7.htm 00500 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00505 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.interceptpharma.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 10101 - Disclosure - Overview of Business Sheet http://www.interceptpharma.com/role/DisclosureOverviewOfBusiness Overview of Business Notes 9 false false R10.htm 10201 - Disclosure - Basis of Presentation Sheet http://www.interceptpharma.com/role/DisclosureBasisOfPresentation Basis of Presentation Notes 10 false false R11.htm 10301 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 10401 - Disclosure - Cash, Cash Equivalents and Investment Debt Securities Sheet http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecurities Cash, Cash Equivalents and Investment Debt Securities Notes 12 false false R13.htm 10501 - Disclosure - Fair Value Measurements Sheet http://www.interceptpharma.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 10601 - Disclosure - Fixed Assets, Net Sheet http://www.interceptpharma.com/role/DisclosureFixedAssetsNet Fixed Assets, Net Notes 14 false false R15.htm 10701 - Disclosure - Inventory Sheet http://www.interceptpharma.com/role/DisclosureInventory Inventory Notes 15 false false R16.htm 10801 - Disclosure - Leases Sheet http://www.interceptpharma.com/role/DisclosureLeases Leases Notes 16 false false R17.htm 10901 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities Sheet http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilities Accounts Payable, Accrued Expenses and Other Liabilities Notes 17 false false R18.htm 11001 - Disclosure - Long-Term Debt Sheet http://www.interceptpharma.com/role/DisclosureLongTermDebt Long-Term Debt Notes 18 false false R19.htm 11101 - Disclosure - Product Revenue, Net Sheet http://www.interceptpharma.com/role/DisclosureProductRevenueNet Product Revenue, Net Notes 19 false false R20.htm 11201 - Disclosure - License Agreement Sheet http://www.interceptpharma.com/role/DisclosureLicenseAgreement License Agreement Notes 20 false false R21.htm 11301 - Disclosure - Stockholders' Equity Sheet http://www.interceptpharma.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 21 false false R22.htm 11401 - Disclosure - Stock Compensation Sheet http://www.interceptpharma.com/role/DisclosureStockCompensation Stock Compensation Notes 22 false false R23.htm 11501 - Disclosure - Net Loss Per Share Sheet http://www.interceptpharma.com/role/DisclosureNetLossPerShare Net Loss Per Share Notes 23 false false R24.htm 11601 - Disclosure - Commitments and Contingencies Sheet http://www.interceptpharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 20202 - Disclosure - Basis of Presentation (Policy) Sheet http://www.interceptpharma.com/role/DisclosureBasisOfPresentationPolicy Basis of Presentation (Policy) Policies http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 25 false false R26.htm 20302 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 26 false false R27.htm 20502 - Disclosure - Fair Value Measurements (Policy) Sheet http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsPolicy Fair Value Measurements (Policy) Policies http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 27 false false R28.htm 30303 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies 28 false false R29.htm 30403 - Disclosure - Cash, Cash Equivalents and Investment Debt Securities (Tables) Sheet http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecuritiesTables Cash, Cash Equivalents and Investment Debt Securities (Tables) Tables http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecurities 29 false false R30.htm 30503 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.interceptpharma.com/role/DisclosureFairValueMeasurements 30 false false R31.htm 30603 - Disclosure - Fixed Assets, Net (Tables) Sheet http://www.interceptpharma.com/role/DisclosureFixedAssetsNetTables Fixed Assets, Net (Tables) Tables http://www.interceptpharma.com/role/DisclosureFixedAssetsNet 31 false false R32.htm 30703 - Disclosure - Inventory (Tables) Sheet http://www.interceptpharma.com/role/DisclosureInventoryTables Inventory (Tables) Tables http://www.interceptpharma.com/role/DisclosureInventory 32 false false R33.htm 30803 - Disclosure - Leases (Tables) Sheet http://www.interceptpharma.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.interceptpharma.com/role/DisclosureLeases 33 false false R34.htm 30903 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Tables) Sheet http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilitiesTables Accounts Payable, Accrued Expenses and Other Liabilities (Tables) Tables http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilities 34 false false R35.htm 31003 - Disclosure - Long-Term Debt (Tables) Sheet http://www.interceptpharma.com/role/DisclosureLongTermDebtTables Long-Term Debt (Tables) Tables http://www.interceptpharma.com/role/DisclosureLongTermDebt 35 false false R36.htm 31103 - Disclosure - Product Revenue, Net (Tables) Sheet http://www.interceptpharma.com/role/DisclosureProductRevenueNetTables Product Revenue, Net (Tables) Tables http://www.interceptpharma.com/role/DisclosureProductRevenueNet 36 false false R37.htm 31403 - Disclosure - Stock Compensation (Tables) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationTables Stock Compensation (Tables) Tables http://www.interceptpharma.com/role/DisclosureStockCompensation 37 false false R38.htm 31503 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.interceptpharma.com/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.interceptpharma.com/role/DisclosureNetLossPerShare 38 false false R39.htm 40301 - Disclosure - Summary of Significant Accounting Policies (Allowance for credit losses) (Details) Sheet http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAllowanceForCreditLossesDetails Summary of Significant Accounting Policies (Allowance for credit losses) (Details) Details http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 40302 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 40401 - Disclosure - Cash, Cash Equivalents and Investment Debt Securities (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecuritiesNarrativeDetails Cash, Cash Equivalents and Investment Debt Securities (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecuritiesTables 41 false false R42.htm 40402 - Disclosure - Cash, Cash Equivalents and Investment Debt Securities (Cash, Cash Equivalents and Investment Debt Securities) (Details) Sheet http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecuritiesCashCashEquivalentsAndInvestmentDebtSecuritiesDetails Cash, Cash Equivalents and Investment Debt Securities (Cash, Cash Equivalents and Investment Debt Securities) (Details) Details http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentDebtSecuritiesTables 42 false false R43.htm 40403 - Disclosure - Cash, Cash Equivalents, and Investments (Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value) (Details) Sheet http://www.interceptpharma.com/role/DisclosureCashCashEquivalentsAndInvestmentsAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetails Cash, Cash Equivalents, and Investments (Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value) (Details) Details 43 false false R44.htm 40501 - Disclosure - Fair Value Measurements (Fair Value, Marketable Securities Measured on Recurring and Nonrecurring Basis) (Details) Sheet http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsFairValueMarketableSecuritiesMeasuredOnRecurringAndNonrecurringBasisDetails Fair Value Measurements (Fair Value, Marketable Securities Measured on Recurring and Nonrecurring Basis) (Details) Details http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsTables 44 false false R45.htm 40502 - Disclosure - Fair Value Measurements (Schedule of Available for Sale Securities Debt Maturities) (Details) Sheet http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsScheduleOfAvailableForSaleSecuritiesDebtMaturitiesDetails Fair Value Measurements (Schedule of Available for Sale Securities Debt Maturities) (Details) Details http://www.interceptpharma.com/role/DisclosureFairValueMeasurementsTables 45 false false R46.htm 40602 - Disclosure - Fixed Assets, Net (Fixed Assets Stated at Cost) (Details) Sheet http://www.interceptpharma.com/role/DisclosureFixedAssetsNetFixedAssetsStatedAtCostDetails Fixed Assets, Net (Fixed Assets Stated at Cost) (Details) Details http://www.interceptpharma.com/role/DisclosureFixedAssetsNetTables 46 false false R47.htm 40701 - Disclosure - Inventory (Schedule of Inventory) (Details) Sheet http://www.interceptpharma.com/role/DisclosureInventoryScheduleOfInventoryDetails Inventory (Schedule of Inventory) (Details) Details http://www.interceptpharma.com/role/DisclosureInventoryTables 47 false false R48.htm 40801 - Disclosure - Leases (Details) Sheet http://www.interceptpharma.com/role/DisclosureLeasesDetails Leases (Details) Details http://www.interceptpharma.com/role/DisclosureLeasesTables 48 false false R49.htm 40802 - Disclosure - Leases (Assets and Liabilities) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLeasesAssetsAndLiabilitiesDetails Leases (Assets and Liabilities) (Details) Details http://www.interceptpharma.com/role/DisclosureLeasesTables 49 false false R50.htm 40803 - Disclosure - Leases (Lease Cost, Term and Discount Rate) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLeasesLeaseCostTermAndDiscountRateDetails Leases (Lease Cost, Term and Discount Rate) (Details) Details http://www.interceptpharma.com/role/DisclosureLeasesTables 50 false false R51.htm 40804 - Disclosure - Leases (Maturities of Operating Lease Liabilities and lease payments) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLeasesMaturitiesOfOperatingLeaseLiabilitiesAndLeasePaymentsDetails Leases (Maturities of Operating Lease Liabilities and lease payments) (Details) Details http://www.interceptpharma.com/role/DisclosureLeasesTables 51 false false R52.htm 40901 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilitiesNarrativeDetails Accounts Payable, Accrued Expenses and Other Liabilities (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilitiesTables 52 false false R53.htm 40902 - Disclosure - Accounts Payable, Accrued Expenses and Other Liabilities (Schedule of Accounts Payable and Accrued Liabilities) (Details) Sheet http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilitiesScheduleOfAccountsPayableAndAccruedLiabilitiesDetails Accounts Payable, Accrued Expenses and Other Liabilities (Schedule of Accounts Payable and Accrued Liabilities) (Details) Details http://www.interceptpharma.com/role/DisclosureAccountsPayableAccruedExpensesAndOtherLiabilitiesTables 53 false false R54.htm 41001 - Disclosure - Long-Term Debt (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLongTermDebtNarrativeDetails Long-Term Debt (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureLongTermDebtTables 54 false false R55.htm 41002 - Disclosure - Long-Term Debt (Schedule of Long-term Debt Instruments) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLongTermDebtScheduleOfLongTermDebtInstrumentsDetails Long-Term Debt (Schedule of Long-term Debt Instruments) (Details) Details http://www.interceptpharma.com/role/DisclosureLongTermDebtTables 55 false false R56.htm 41101 - Disclosure - Product Revenue, Net (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureProductRevenueNetNarrativeDetails Product Revenue, Net (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureProductRevenueNetTables 56 false false R57.htm 41102 - Disclosure - Product Revenue, Net (Schedule of Product Revenue, Net) (Details) Sheet http://www.interceptpharma.com/role/DisclosureProductRevenueNetScheduleOfProductRevenueNetDetails Product Revenue, Net (Schedule of Product Revenue, Net) (Details) Details http://www.interceptpharma.com/role/DisclosureProductRevenueNetTables 57 false false R58.htm 41201 - Disclosure - License Agreement (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureLicenseAgreementNarrativeDetails License Agreement (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureLicenseAgreement 58 false false R59.htm 41301 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureStockholdersEquity 59 false false R60.htm 41401 - Disclosure - Stock Compensation (Narrative) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationNarrativeDetails Stock Compensation (Narrative) (Details) Details http://www.interceptpharma.com/role/DisclosureStockCompensationTables 60 false false R61.htm 41402 - Disclosure - Stock Compensation (Schedule of Share Based Compensation Arrangement By Share Based Payment Award Grants in Period Fair Value Assumptions) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardGrantsInPeriodFairValueAssumptionsDetails Stock Compensation (Schedule of Share Based Compensation Arrangement By Share Based Payment Award Grants in Period Fair Value Assumptions) (Details) Details http://www.interceptpharma.com/role/DisclosureStockCompensationTables 61 false false R62.htm 41403 - Disclosure - Stock Compensation (Schedule of Share Based Compensation Stock Options Activities) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationScheduleOfShareBasedCompensationStockOptionsActivitiesDetails Stock Compensation (Schedule of Share Based Compensation Stock Options Activities) (Details) Details http://www.interceptpharma.com/role/DisclosureStockCompensationTables 62 false false R63.htm 41404 - Disclosure - Stock Compensation (Schedule of Share-based Compensation, Restricted Stock Units and Award Activity) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationScheduleOfShareBasedCompensationRestrictedStockUnitsAndAwardActivityDetails Stock Compensation (Schedule of Share-based Compensation, Restricted Stock Units and Award Activity) (Details) Details http://www.interceptpharma.com/role/DisclosureStockCompensationTables 63 false false R64.htm 41405 - Disclosure - Stock Compensation (Schedule of Stock Based Compensation Expense) (Details) Sheet http://www.interceptpharma.com/role/DisclosureStockCompensationScheduleOfStockBasedCompensationExpenseDetails Stock Compensation (Schedule of Stock Based Compensation Expense) (Details) Details http://www.interceptpharma.com/role/DisclosureStockCompensationTables 64 false false R65.htm 41501 - Disclosure - Net Loss Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) Sheet http://www.interceptpharma.com/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Net Loss Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) Details http://www.interceptpharma.com/role/DisclosureNetLossPerShareTables 65 false false All Reports Book All Reports icpt-20200511x10q.htm icpt-20200331xex31d1.htm icpt-20200331xex31d2.htm icpt-20200331xex32d1.htm icpt-20200511.xsd icpt-20200511_cal.xml icpt-20200511_def.xml icpt-20200511_lab.xml icpt-20200511_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true